$PL

Johnson Ashley F. sold $773K of PL (indirect holdings)

Johnson Ashley F. (President & CFO) sold 34,993 indirectly-held shares of Planet Labs PBC (PL) at $22.08 ($0.77M total) on 2026-07-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Johnson Ashley F.
Published Jul 24, 2026, 8:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PL
Neutral
high confidence
Mentioned
$PL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price ($22.0804/share), and that it was executed under a pre-arranged 10b5-1 plan; no new company performance or guidance is included.

02

Market read

Traders may briefly reassess sentiment around insider activity, but the 10b5-1 framing reduces fundamental interpretation.

03

What to watch

Indirect holdings and the post-sale share count are provided, but the article does not disclose whether other insiders sold/bought around the same time, limiting signal strength.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-24, transaction dated 2026-07-23 (after-hours/next-session read-through).

Background

This is an SEC Form 4 insider transaction disclosure for Planet Labs PBC, reported by the President and CFO via indirect holdings.

Company-level read

Ticker impact

$PLNeutralHigh confidence
Context

Planet Labs PBC Form 4 shows CFO Ashley Johnson sold 34,993 shares for about $772.7K under a 10b5-1 plan on 2026-07-23.

Expected impact

Low likelihood of sustained price impact; any reaction is likely limited to intraday sentiment around insider-selling headlines.

Evidence & confidence

The filing is a disclosed open-market sale, explicitly under a pre-arranged Rule 10b5-1 plan, with no accompanying new operational or financial guidance in the text.

Market effects

Minimal; this is company-specific insider transaction with no sector-wide catalyst described.

None indicated.

None indicated.

Counterpoint

Because it is a 10b5-1 plan, the sale may reflect scheduled liquidity needs rather than bearish expectations, so traders may ignore it for fundamental direction.

Key entities

  • Planet Labs PBC

    Company whose insider transaction is disclosed on Form 4.

  • Ashley F. Johnson

    President and CFO who sold shares under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PLMed

Planet Labs PBC Q2 2027 Earnings Call Summary

Planet Labs PBC reported Q2 2027 revenue growth of 58% YoY, driven by Satellite Services and Defense sectors. Non-GAAP gross margins reached 59%. The company increased CapEx guidance to $100M-$115M for next-gen constellations and maintains $850M in cash. Management highlighted a $4B pipeline for Satellite Services and strategic expansion in Europe.

$PLHighAI 8/10

Planet Labs Shares Jump After Q2 Results Beat Expectations

Planet Labs (PL) reported Q2 2027 revenue of $116.1M, up 58% YoY, beating estimates. Adjusted EPS was $0.02, surpassing expectations. Defense and intelligence revenue rose 90% YoY. The company raised FY2027 revenue guidance to $430M-$441M. Shares rose 14.1% in pre-market trading.

$PLHighAI 8/10

Planet Labs Rallies 10% as Record Revenue Overrides Soft Q3 Guidance

Planet Labs (PL) stock rose 10% after reporting Q2 revenue of $116.1M, beating estimates by 11%, and adjusted EPS of $0.02, reversing a pre-earnings decline. Despite softer Q3 guidance, the company highlights a $4B sovereign satellite-services pipeline. Defense and intelligence revenue grew over 90% YoY, and non-GAAP gross margin was 59%.